NCT04791865Completed
Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to inform scale-up and sustainability of pediatric disclosure.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 748 (actual)
- First submitted
- 5 Mar 2021
- Start date
- 15 Jun 2021
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Boston University
- Diseases
- HIV
- NCT number
- NCT04791865
What you commit to
- Study type: Interventional
- Participants enrolled: 748
- From 15 Jun 2021 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- HIV-infected children less than 7 years
- HIV-infected children with congenital or developmental disorders
- HIV-infected children with comorbidities such as sickle cell disease or diabetes that require frequent clinic visits or hospitalizations
- Children with AIDS-defining illness or end stage AIDS.
Who the study is looking for
- HIV infected children
- Children between the ages of 7-18 who do not know their HIV diagnosis (based on caregiver account and medical records confirmation) and their caregivers will be eligible to participate in the study
Age in the registry: 7 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Korle Bu Teaching Hospital Coordinator of this site? Confirm its status | Accra | Ghana | Unknown status |
Related publications
- Changes in caregiver psychosocial factors known to affect pediatric HIV disclosure: the Sankofa clinical trial experience in Ghana (2013-2023).AIDS Care · 2026 · PMID 41330401
- Scale-up of a paediatric HIV disclosure intervention in Ghana using a stepped wedge cluster randomised trial design: Sankofa 2 protocol and implementation.BMJ Open · 2025 · PMID 41238360
This page is information, not medical advice. Discuss any trial with your doctor.